TSSI · XBRL financial data

TSS financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (TSSI's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	—	—	—	54,399	148,144	245,719
Revenue from contracts with customers	45,062	27,410	30,637	54,399	148,144	245,719
Cost of revenue	38,259	21,049	21,657	43,398	125,793	213,337
Gross profit	6,803	6,361	8,980	11,001	22,351	32,382
Selling, general and administrative	6,674	6,656	7,683	8,931	13,240	20,650
Total operating expenses	—	—	—	11,222	13,848	26,060
Operating income (loss)	(400)	(831)	914	1,750	8,503	6,322
Interest expense	367	430	964	1,616	2,737	—
Other income (expense)	896	—	—	0	194	—
Income tax expense (benefit)	50	65	56	60	158	(7,592)
Net income (loss)	79	(1,297)	(73)	74	5,976	15,125
Earnings per share, basic USD per share	0.00	(0.07)	0.00	0.00	0.27	0.61
Earnings per share, diluted USD per share	0.00	(0.07)	0.00	0.00	0.24	0.56
Weighted average shares, basic thousands of shares	17,820	18,363	20,061	21,602	—	—
Weighted average shares, diluted thousands of shares	20,988	18,363	20,061	22,021	25,075	27,222

Fiscal years (TSSI's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	19,012	7,992	20,397	11,831	23,222	85,510
Inventory	197	847	862	2,343	17,673	15,966
Prepaid and other current assets	58	550	175	302	248	1,642
Total current assets	20,988	11,808	24,410	19,313	58,197	118,630
Property and equipment, net	662	281	587	628	8,591	38,076
Right-of-use asset	876	5,566	4,717	4,062	24,213	15,294
Goodwill	780	780	780	780	780	780
Total assets	23,808	19,281	31,406	25,600	96,568	184,935
Accounts payable	12,550	5,472	19,959	12,414	35,770	—
Accrued liabilities	453	703	—	746	155,230	3,723
Current portion of long-term debt	0	2,023	0	—	0	4,010
Total current liabilities	18,084	12,118	24,163	18,420	56,919	72,567
Long-term debt	2,234	0	0	0	8,200	14,004
Lease liability, non-current	208	4,938	4,309	3,631	23,540	21,629
Total liabilities	20,625	17,078	28,472	22,051	89,430	108,300
Accumulated deficit	(65,015)	(66,312)	(66,385)	(66,311)	(60,335)	(45,210)
Total stockholders' equity	3,183	2,203	2,934	3,549	7,138	76,635
Total liabilities and equity	23,808	19,281	31,406	25,600	96,568	184,935
Common shares outstanding (cover page) thousands of shares	17,959	18,868	21,542	21,773	25,029	27,774

Fiscal years (TSSI's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	79	(1,297)	(73)	74	5,976	15,125
Stock-based compensation	392	469	530	581	1,235	3,956
Depreciation and amortization	529	536	383	320	—	—
Net cash from operating activities	9,997	(10,452)	14,712	(8,269)	15,296	34,863
Net cash from investing activities	(396)	(64)	(536)	(257)	(8,483)	(32,743)
Proceeds from issuing common stock	2	45	41	0	—	—
Share repurchases	174	197	134	40	4,485	4,904
Proceeds from long-term debt	890	—	—	0	8,200	16,334
Repayments of long-term debt	—	352	2,045	0	0	6,582
Net cash from financing activities	733	(504)	(1,771)	(40)	4,578	60,168
Net change in cash	10,334	(11,020)	12,405	(8,566)	—	—

SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
TSS	67,679	35,141	7,633*	28.2M	—	Q2 FY26 10-Q/AJun 30, 2026
V2X	265,070	1,271,463	67,319*	31.4M	—	Q3 FY26 10-QOct 2, 2026
Onterris	12,724	186,661	6,156*	35.1M	—	Q2 FY26 10-QJun 30, 2026
Hackett Group	14,162	69,328	15,160*	24.9M	—	Q2 FY26 10-QJun 26, 2026
Bowman Consulting Group	10,486	146,125	(7,873)*	17.3M	1.3 quarters	Q2 FY26 10-QJun 30, 2026
Franklin Covey	11,972	67,807	1,125*	11.3M	—	Q3 FY26 10-QMay 31, 2026
Astrana Health	400,792	972,520	32,748*	55.7M	—	Q2 FY26 10-QJun 30, 2026
Evolent Health	115,703	652,520	(9,312)*	113.1M	12.4 quarters	Q2 FY26 10-QJun 30, 2026
RMR Group	58,203	153,514	23,368*	not reported	—	Q3 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.